Biochips enable the accurate, rapid, and high-throughput detection of DNA, RNA, polypeptides, proteins, cells, tissues, and other biological components, with great advantages in disease screening and early diagnosis.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

The global point of care (POC) molecular diagnostics market is expected to grow at a CAGR of close to 14% during the period 2019-2023, driven mainly by the growing number of MAs and collaborations, and rising focus on next-generation product

Luminex Corporation (Austin, Texas, USA) has completed its previously announced acquisition of MilliporeSigmas (Burlington, MA, USA) flow cytometry portfolio. Luminex offers a wide range of solutions applicable in diverse markets, including

The US Food and Drug Administration today granted de novo clearance that permits marketing of Hologics Aptima assay for Mycoplasma genitalium sexually-transmitted infection in men and women. The FDA said that this is the first test it has au

The global urinalysis market is expected to grow at a steady CAGR of 5.40% over the 2016-2024 period to reach a value of USD 1.5 billion by the end of 2024, propelled mainly by the rising incidence of diabetes and urinal infections, globally

Beckman Coulter (Brea, CA, USA) has launched the ClearLLab 10C System for clinical flow cytometry labs that includes the first 10-color CE-IVD panels of immunophenotyping reagents for both lymphoid and myeloid lineages. The four ClearLLab 10

Abbott said Wednesday that its fourth quarter diagnostic revenues grew 3 percent year over year on a reported basis and 7 percent on an organic basis to $1.96 billion from $1.91 billion in the year-ago period. For the three months ended Dec.

Illumina reported after the close of the market recently that its fourth quarter 2018 revenues rose by 11 percent, echoing its pre-announcement forecast at the JP Morgan Healthcare conference earlier this month. The San Diego-based company

Recently, it was reported that Thermo Fisher Scientific had signed a definitive agreement to sell its anatomical pathology business to PHC Holdings Corporation for $1.14 billion. Thermo Fishersanatomy pathology business provides microscope s

BATM Advanced Communications, an Israeli firm focused on real-time technologies for networking and medical laboratories, has agreed to invest up to $30 million in Ador Diagnostics, BATMs joint venture with Gamida for Life. The funds will go

Becton Dickinson reported recently that preliminary estimates show fiscal first quarter revenues increased 35 percent, primarily due to the acquisition of C.R. Bard. The firm reported preliminary revenues of $4.16 billion, compared to $3.08